Evidence map›Paper›PMID 34303707›Full record

ArticleThe Journal of biological chemistry2021

Metformin inhibits MAPK signaling and rescues pancreatic aquaporin 7 expression to induce insulin secretion in type 2 diabetes mellitus.

Xueting He, Fei Gao, Jiaojiao Hou, Tingjie Li, Jiang Tan, Chunyu Wang, Xiaoyan Liu, Maoqi Wang, Hui Liu, Yuqin Chen and 2 more

Open access · goldAbstract read
In one paragraph

Article in The Journal of biological chemistry, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 35 papers.

0numbers the graph read from it
0cells of the map it votes in
35citing papers in PubMed
7.5field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

35 citing papers in PubMed, 50 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Network pharmacology-based study on the mechanism of Tangfukang formula against type 2 diabetes mellitus.Journal of traditional Chinese medicine = Chung i tsa chih ying wen pan · 2025
    Article
  13. Article
  14. Article
  15. Article
  16. Review
  17. Antidiabetic and Anti-Inflammatory Effect ofPharmaceuticals (Basel, Switzerland) · 2024
    Article
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 2 institutions in 1 country.

Xueting HeDepartment of Anatomy, College of Basic Medicine, Chongqing Medical University, Chongqing, People's Republic of China.
Fei GaoDepartment of Urology, The First Affiliated Hospital, Chongqing Medical University, Chongqing, People's Republic of China.
Jiaojiao HouDepartment of Anatomy, College of Basic Medicine, Chongqing Medical University, Chongqing, People's Republic of China.
Tingjie LiDepartment of Anatomy, College of Basic Medicine, Chongqing Medical University, Chongqing, People's Republic of China.
Jiang TanDepartment of Anatomy, College of Basic Medicine, Chongqing Medical University, Chongqing, People's Republic of China.
Chunyu WangDepartment of Anatomy, College of Basic Medicine, Chongqing Medical University, Chongqing, People's Republic of China.
Xiaoyan LiuDepartment of Anatomy, College of Basic Medicine, Chongqing Medical University, Chongqing, People's Republic of China.
Maoqi WangDepartment of Anatomy, College of Basic Medicine, Chongqing Medical University, Chongqing, People's Republic of China.
Hui LiuDepartment of Anatomy, College of Basic Medicine, Chongqing Medical University, Chongqing, People's Republic of China.
Yuqin ChenInstitute of Neuroscience, College of Basic Medicine, Chongqing Medical University, Chongqing, People's Republic of China.
Zhuoyuan YuDepartment of Urology, The First Affiliated Hospital, Chongqing Medical University, Chongqing, People's Republic of China.
Mei YangDepartment of Anatomy, College of Basic Medicine, Chongqing Medical University, Chongqing, People's Republic of China. Electronic address: yangmei503@cqmu.edu.cn.
Chongqing Medical University · CNThe Affiliated Yongchuan Hospital of Chongqing Medical University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Metformin is the first-line antidiabetic agent for type 2 diabetes mellitus (T2DM) treatment. Although accumulated evidence has shed light on the consequences of metformin action, the precise mechanisms of its action, especially in the pancreas, are not fully understood. Aquaporin 7 (AQP7) acts as a critical regulator of intraislet glycerol content, which is necessary for insulin production and secretion. The aim of this study was to investigate the effects of different doses of metformin on AQP7 expression and explore the possible mechanism of its protective effects in the pancreatic islets. We used an in vivo model of high-fat diet in streptozocin-induced diabetic rats and an in vitro model of rat pancreatic β-cells (INS-1 cells) damaged by hyperglycemia and hyperlipidemia. Our data showed that AQP7 expression levels were decreased, whereas p38 and JNK mitogen-activated protein kinases (MAPKs) were activated in vivo and in vitro in response to hyperglycemia and hyperlipidemia. T2DM rats treated with metformin demonstrated a reduction in blood glucose levels and increased regeneration of pancreatic β-cells. In addition, metformin upregulated AQP7 expression as well as inhibited activation of p38 and JNK MAPKs both in vivo and in vitro. Overexpression of AQP7 increased glycerol influx into INS-1 cells, whereas inhibition of AQP7 reduced glycerol influx, thereby decreasing subsequent insulin secretion. Our findings demonstrate a new mechanism by which metformin suppresses the p38 and JNK pathways, thereby upregulating pancreatic AQP7 expression and promoting glycerol influx into pancreatic β-cells and subsequent insulin secretion in T2DM.

Indexed as

AnimalsAquaporinsCells, CulturedDiabetes Mellitus, ExperimentalDiabetes Mellitus, Type 2Disease Models, AnimalHypoglycemic AgentsInsulinInsulin-Secreting CellsMaleMAP Kinase Signaling SystemMetforminRatsAqp7 protein, ratAquaporinsHypoglycemic AgentsInsulinMetforminaquaporin 7 (AQP7)diabetesMAPKmetforminpancreas

Identifiers

PMID34303707
PMCPMC8374641
OpenAlexW3183581140

What OpenQuestion holds

Texttitle and abstract
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.